Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
European Journal of Immunology|August 7, 2010
Commensal microflora and interferon-gamma promote steady-state interleukin-7 production in vivoShabnam Shalapour, Katrin Deiser, Ozen Sercan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLsBernhard Frankenberger, Heike Pohla, Elfriede Noessner, et al.Cancers|April 12, 2022
Isolation of Neoantigen-Specific Human T Cell Receptors from Different Human and Murine RepertoiresCorinna Grunert, Gerald Willimsky, Caroline Anna Peuker, et al.Immunity|October 23, 2012
The sorting receptor Sortilin exhibits a dual function in exocytic trafficking of interferon-γ and granzyme A in T cellsStefanie Herda, Friederike Raczkowski, Hans-Willi Mittrücker, et al.Cancer Immunology, Immunotherapy : CII|January 31, 2018
Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies-the German Cancer Consortium approachAngela M Krackhardt, Brigitte Anliker, Martin Hildebrandt, et al.Proceedings of the National Academy of Sciences of the United States of America|March 14, 2018
CD96 expression determines the inflammatory potential of IL-9-producing Th9 cellsKatarina Stanko, Christina Iwert, Christine Appelt, et al.Human Gene Therapy|October 1, 2009
Phase 1 trial of allogeneic gene-modified tumor cell vaccine RCC-26/CD80/IL-2 in patients with metastatic renal cell carcinomaAlexander Buchner, Heike Pohla, Gerald Willimsky, et al.Cancer Immunology Research|January 18, 2017
Tumor-Infiltrating Merkel Cell Polyomavirus-Specific T Cells Are Diverse and Associated with Improved Patient SurvivalNatalie J Miller, Candice D Church, Lichun Dong, et al.Cancer Research|May 24, 2017
Chimeric PD-1:28 Receptor Upgrades Low-Avidity T cells and Restores Effector Function of Tumor-Infiltrating Lymphocytes for Adoptive Cell TherapyRamona Schlenker, Luis Felipe Olguín-Contreras, Matthias Leisegang, et al.Cell Reports|October 27, 2021
Lymphocyte access to lymphoma is impaired by high endothelial venule regressionLutz Menzel, Maria Zschummel, Tadhg Crowley, et al.Pageof 5